Pharmaceutical Technology

JANUARY 17, 2023

Nonetheless, patients receiving the current standard of care, Novo Nordisk’s Wegovy (injectable semaglutide), are expected to self-administer treatment on a weekly basis. Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies.

Marketing 52

Marketing Patients Safety Pharmaceutical 52

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Wegovy has been associated with a 12.4% An immediate high demand for the drug and a shortage of Wegovy resulted in supply issues. compared to a 5.1%

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Wegovy has been associated with a 12.4% An immediate high demand for the drug and a shortage of Wegovy resulted in supply issues. compared to a 5.1%

Medical 98

Medical Manufacturing Insurance Side effects 98